Feline PA antibody and antigen (recombinant protein)

Diagnostic anti-Feline PA antibodies pairs and antigen for animal health (animal Cat/Feline liver disease, inflammation, or tissue death) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-FEL-PA-Ag01 Recombinant Feline PA protein 3090
GMP-FEL-PA-Ab01 Anti-Feline PA mouse monoclonal antibody (mAb) 1953
GMP-FEL-PA-Ab02 Anti-Feline PA mouse monoclonal antibody (mAb) 1953
GMP-FEL-PA-Ab03 Anti-Feline PA human monoclonal antibody (mAb) 1953
GMP-FEL-PA-Ab04 Anti-Feline PA human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-FEL-PA-Ag01
Product Name Recombinant Feline PA protein
Target/Biomarker Feline Prealbumin (PA)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Feline Prealbumin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PA level test of animal Cat/Feline with liver disease, inflammation, or tissue death.
Tag His
Products description Recombinant Feline PA protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-FEL-PA-Ab01, GMP-FEL-PA-Ab02
Product Name Anti-Feline PA mouse monoclonal antibody (mAb)
Target/Biomarker Feline Prealbumin (PA)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Feline Prealbumin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-PA antibodies in PA level test of animal Cat/Feline with liver disease, inflammation, or tissue death.
Tag mFc
Products description Anti-Feline PA mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-PA antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-FEL-PA-Ab03, GMP-FEL-PA-Ab04
Product Name Anti-Feline PA human monoclonal antibody (mAb)
Target/Biomarker Feline Prealbumin (PA)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Feline Prealbumin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-PA antibodies in PA level test of animal Cat/Feline with liver disease, inflammation, or tissue death.
Tag hFc
Products description Anti-Feline PA human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-PA antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Feline Prothrombin Activation Fragment 1+2 (fPAF1+2) is a biochemical linchpin within the complex landscape of feline hemostasis. Structurally, it represents a fragment arising from the activation of prothrombin (Factor II) into thrombin (Factor IIa), a process governed by a cascade of coagulation factors and platelet interactions. This transformation is fundamental to the initiation of blood clot formation. Prothrombin, an inert precursor protein, circulates uneventfully in the feline bloodstream until the moment of vascular injury. When such an injury occurs, a choreographed sequence of enzymatic reactions ensues, culminating in the cleavage of prothrombin into two fragments: thrombin and fPAF1+2. Thrombin, the multifaceted enzyme that emerges from this process, occupies a pivotal role in the creation of a stable blood clot. It catalyzes the conversion of soluble fibrinogen into insoluble fibrin strands, which serve as the structural framework of a clot. While thrombin takes center stage in fibrin formation, fPAF1+2 assumes a different, yet equally critical, role. Rather than participating directly in clot assembly, it functions as an indispensable marker of ongoing thrombin generation within the feline hemostatic system. Its presence in the bloodstream serves as a dynamic reflection of the equilibrium between prothrombin activation and thrombin regulation.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment